127 related articles for article (PubMed ID: 81476)
61. Immunodiagnosis of human melanoma: characterization of human melanoma antigens and their detection in sera of melanoma patients by radioimmunoassay.
Ishii Y; Mavligit GM
Oncology; 1982; 39(1):23-8. PubMed ID: 6173826
[TBL] [Abstract][Full Text] [Related]
62. Immunology of human malignant melanoma.
Lewis MG
Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
[No Abstract] [Full Text] [Related]
63. [Immunologic reaction-readiness in malignant melanoma].
Bickhardt R; Kunze J
Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
[No Abstract] [Full Text] [Related]
64. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
[TBL] [Abstract][Full Text] [Related]
65. [Local immunotherapy. Alternative therapy for malignant cutaneous lesions (demonstration on 30 patients with malignant melanoma) (author's transl)].
Kokoschka EM; Micksche M
Wien Klin Wochenschr; 1979 Mar; 91(5):150-4. PubMed ID: 425533
[TBL] [Abstract][Full Text] [Related]
66. [Standardized recall antigen testing in patients with malignant melanoma, endogenous eczema patients and healthy humans].
Stenger D; Delbrück H; Krumrey K; Zaun H
Z Hautkr; 1983 Mar; 58(5):293-304. PubMed ID: 6845797
[TBL] [Abstract][Full Text] [Related]
67. Tumour specificity of the SCM test for cancer diagnosis.
Chaitchik S; Asher O; Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
[TBL] [Abstract][Full Text] [Related]
68. [Mitogenic activity of melanoma extracts in leucocyte cultures (author's transl)].
Lischka G
Arch Dermatol Res (1975); 1975 Sep; 253(2):105-12. PubMed ID: 1190833
[TBL] [Abstract][Full Text] [Related]
69. Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.
Flavell DJ; Potter CW
Br J Cancer; 1978 Jan; 37(1):15-22. PubMed ID: 74259
[TBL] [Abstract][Full Text] [Related]
70. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
71. Reactivity of human lymphocytes to teratoma preparations as revealed by the macrophage electrophoretic mobility (MEM) technique.
Irmscher J; Grossmann H; Kotzsch M; Wagner H; Müller M
Arch Geschwulstforsch; 1982; 52(5):349-53. PubMed ID: 7149908
[TBL] [Abstract][Full Text] [Related]
72. Macrophage electrophoretic mobility (MEM) with myelin basic protein.
Rawlins GA; Wood JM; Bagshawe KD
Br J Cancer; 1976 Dec; 34(6):613-8. PubMed ID: 1008988
[TBL] [Abstract][Full Text] [Related]
73. Cellular sensitization in tumor-bearing mice to soluble extracts from normal and malignant tissues. I. Common and individually distinct antigens as detected by electrophoretic mobility (EM) test.
Werner H; Jenssen HL; Köhler H; von Broen B; Pasternak G; Thuy LT; Schlott B; Pasternak L
Eur J Cancer (1965); 1978 May; 14(5):485-90. PubMed ID: 77224
[No Abstract] [Full Text] [Related]
74. Cellular immune reaction to human malignant melanoma and breast carcinoma cells.
Canevari S; Fossati G; Della Porta G
J Natl Cancer Inst; 1976 Apr; 56(4):705-9. PubMed ID: 1255793
[TBL] [Abstract][Full Text] [Related]
75. [Electrophoretic mobility test in the early diagnosis of malignant tumors; findings in the prestages of cervical and breast cancers].
Tautz C; Bögelspacher HR; Klaissle K
Onkologie; 1979 Oct; 2(5):199-203. PubMed ID: 94155
[TBL] [Abstract][Full Text] [Related]
76. IgA as a blocking factor in human malignant melanoma.
O'Neill PA; Romsdahl MM
Immunol Commun; 1974; 3(5):427-38. PubMed ID: 4214759
[No Abstract] [Full Text] [Related]
77. A study of cellular inflammatory reaction in human malignant melanoma, using in vitro-labelling techniques with h3-thymidine.
Pullmann H; Steigleder GK
Arch Dermatol Forsch; 1974 Apr; 249(3):285-89. PubMed ID: 4840894
[No Abstract] [Full Text] [Related]
78. A nude mouse tumor neutralization test applied to patients suffering from skin melanoma. A methodological study.
Kristensen E
Proc Soc Exp Biol Med; 1977 May; 155(1):27-30. PubMed ID: 859877
[No Abstract] [Full Text] [Related]
79. Cancer diagnostic test of Field and Caspary: Part II. A review and interpretation of the collected data.
Kast RE
Med Hypotheses; 1980 Jan; 6(1):63-72. PubMed ID: 6155596
[TBL] [Abstract][Full Text] [Related]
80. The use of leukocyte cell line culture supernatant for skin reaction testing in malignant melanoma.
Rios A; Hersh EM; Gutterman JU; Mavligit GM; Schimek H; McEntire JE; Papermaster BW
Cancer; 1979 Nov; 44(5):1615-21. PubMed ID: 498033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
